(Q71669579)

English

Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19

scientific article published on 01 January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

L T Vlasveld

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Hekman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

F A Vyth-Dreese

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C J Melief

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J J Sein

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A C Voordouw

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

T A Dellemijn

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

E M Rankin

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

37-47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01517234

0 references

Monoclonal antibody-based therapies of leukemia and lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia, and selected solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phorbol-ester-mediated induction and augmentation of mitogenesis and interleukin-2 production in human T-cell lymphoproliferative disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of lymphoma directed at idiotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory role of CD19 molecules in B-cell activation and differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 therapy for refractory and relapsing lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The surface antigens of human B lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacterial infections in lymphoma patients treated with recombinant interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humoral and cellular responses of colorectal cancer patients treated with monoclonal antibodies and interferon gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to idiotype inhibit in vitro growth of human B-cell lymphomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group B

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies for treating cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific enhancement of the therapeutic effect of anti-idiotype antibodies on a murine B cell lymphoma by IL-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of high-dose interleukin-2 and lymphokine-activated killer cells in Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of murine monoclonal antibody L6 in combination with subcutaneous interleukin-2 in patients with advanced carcinoma of the breast, colorectum, and lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2 infusion abrogates humoral immune responses in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical trial of anti-idiotype therapy for B cell malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7530170

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01517234

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7530170%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71669579&oldid=1759542009"